Abcellera Biologics Share Price Today
(NASDAQ: ABCL)

Name: Abcellera Biologics Share Price Today (NASDAQ: ABCL) - Abcellera Biologics Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Abcellera Biologics share price is $2.39 & ₹207.86 as on 6 Mar 2025, 2.30 'hrs' IST

$2.39

▲

0.05

(2.14%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Abcellera Biologics share price in Dollar and Rupees. Guide to invest in Abcellera Biologics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Abcellera Biologics, along with analyst recommendations, forecasts, and comprehensive financials.

Abcellera Biologics share price movements

Today's Low: $2.27
Today's High: $2.41
$2.39
5.02%
Downside
Day's Volatility :5.61%
Upside
0.62%
52 Weeks Low: $2.31
52 Weeks High: $5.13
$2.39
3.35%
Downside
52 Weeks Volatility :54.93%
Upside
53.37%

Abcellera Biologics (ABCL) Returns

Period	Abcellera Biologics Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-17.89%	2.1%	0.0%
6 Months	-3.7%	-4.1%	0.0%
1 Year	-51.95%	2.2%	0.0%
3 Years	-71.74%	11.8%	-11.6%

Abcellera Biologics (ABCL) Key Statistics

in dollars & INR

Previous Close	$2.34
Open	$2.37
Today's High	$2.405
Today's Low	$2.27
Market Capitalization	$703.3M
Today's Volume	$579.5K
52 Week High	$5.125
52 Week Low	$2.27
Revenue TTM	$28.8M
EBITDA	$-223.9M
Earnings Per Share (EPS)	$-0.55
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.46%
Return On Equity TTM	-14.75%

How to invest in Abcellera Biologics Stock (ABCL) from India?

It is very easy for Indian residents to invest directly in Abcellera Biologics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Abcellera Biologics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Abcellera Biologics or ABCL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Abcellera Biologics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Abcellera Biologics shares which would translate to 0.364 fractional shares of Abcellera Biologics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Abcellera Biologics, in just a few clicks!

Returns in Abcellera Biologics (ABCL) for Indian investors in Rupees

The Abcellera Biologics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Abcellera Biologics investment value today

Current value as on today

₹54,039

Returns

₹45,961

(-45.96%)

Returns from Abcellera Biologics Stock

₹50,924 (-50.92%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Abcellera Biologics (ABCL)

318.75%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Investment in Abcellera Biologics Shares from India has grown by 318.75% over the past 30 days, indicating increased transactional activity.

-21%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Abcellera Biologics Stock from India on INDmoney has decreased by -21% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Abcellera Biologics

Baker Bros Advisors LP
9.24%
Baillie Gifford & Co Limited.
4.11%
ING Investment Management LLC
3.57%
Capital World Investors
2.66%
Prosight Management, LP
2.47%
UBS Asset Mgmt Americas Inc
1.51%

Analyst Recommendation on Abcellera Biologics

Buy

93%Buy

6%Hold

0%Sell

Based on 15 Wall street analysts offering stock ratings for Abcellera Biologics(by analysts ranked 0 to 5 stars)

Based on 15 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Abcellera Biologics Stock (ABCL)

What analysts predicted

Upside of 396.11%

Target:

$11.86

Current:

$2.39

Insights on Abcellera Biologics Stock (Ticker Symbol: ABCL)

Price Movement
In the last 7 days, ABCL stock has moved down by -19.9%
Decreasing Revenue
Revenue is down for the last 3 quarters, 9.95M → 6.50M (in $), with an average decrease of 18.8% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -36.93M → -51.10M (in $), with an average decrease of 38.4% per quarter
ABCL vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 113.7%
ABCL vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 120.3%
Price to Sales
ForABCL every $1 of sales, investors are willing to pay $23.9, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

ABCL Abcellera Biologics Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$11.6M	↑ 31.49%
Net Income	$-2.4M	↓ 883.14%
Net Profit Margin	-20.84%	↓ 24.34%

	FY20	Y/Y Change
Revenue	$233.2M	↑ 1907.96%
Net Income	$118.9M	↓ 5014.19%
Net Profit Margin	51.0%	↑ 71.84%

	FY21	Y/Y Change
Revenue	$11.6M	↓ 95.02%
Net Income	$-2.2M	↓ 101.86%
Net Profit Margin	-19.04%	↓ 70.04%

	FY22	Y/Y Change
Revenue	$485.4M	↑ 4080.53%
Net Income	$158.5M	↓ 7270.55%
Net Profit Margin	32.66%	↑ 51.7%

	FY23	Y/Y Change
Revenue	$38.0M	↓ 92.17%
Net Income	$-146.4M	↓ 192.35%
Net Profit Margin	-385.0%	↓ 417.66%

	FY24	Y/Y Change
Revenue	$28.8M	↓ 24.17%
Net Income	$-162.9M	↑ 11.24%
Net Profit Margin	-564.83%	↓ 179.83%

	Q2 FY23	Q/Q Change
Revenue	$10.1M	↓ 17.52%
Net Income	$-30.5M	↓ 23.89%
Net Profit Margin	-303.58%	↑ 25.41%

	Q3 FY23	Q/Q Change
Revenue	$6.6M	↓ 34.38%
Net Income	$-28.6M	↓ 6.28%
Net Profit Margin	-433.55%	↓ 129.97%

	Q4 FY23	Q/Q Change
Revenue	$9.2M	↑ 39.1%
Net Income	$-47.2M	↑ 64.8%
Net Profit Margin	-513.67%	↓ 80.12%

	Q1 FY24	Q/Q Change
Revenue	$10.0M	↑ 8.44%
Net Income	$-40.6M	↓ 13.87%
Net Profit Margin	-407.98%	↑ 105.69%

	Q2 FY24	Q/Q Change
Revenue	$7.3M	↓ 26.43%
Net Income	$-36.9M	↓ 9.06%
Net Profit Margin	-504.3%	↓ 96.32%

	Q3 FY24	Q/Q Change
Revenue	$6.5M	↓ 11.14%
Net Income	$-51.1M	↑ 38.39%
Net Profit Margin	-785.42%	↓ 281.12%

	FY19	Y/Y Change
Profit	$1.5M	↓ 83.03%

	FY20	Y/Y Change
Profit	$206.0M	↑ 13647.49%

	FY21	Y/Y Change
Profit	$11.6M	↓ 94.36%

	FY22	Y/Y Change
Profit	$419.0M	↑ 3508.37%

	FY23	Y/Y Change
Profit	$38.0M	↓ 90.92%

	FY24	Y/Y Change
Profit	$28.8M	↓ 24.17%

	Q2 FY23	Q/Q Change
Profit	$2.8M	↓ 106.92%

	Q3 FY23	Q/Q Change
Profit	$-810.0K	↓ 128.93%

	Q4 FY23	Q/Q Change
Profit	$70.0K	↓ 108.64%

	Q1 FY24	Q/Q Change
Profit	$3.2M	↑ 4454.29%

	Q2 FY24	Q/Q Change
Profit	$-30.7M	↓ 1063.43%

	Q3 FY24	Q/Q Change
Profit	$-31.8M	↑ 3.5%

	FY19	Y/Y Change
Operating Cash Flow	$2.7M	↓ 24.44%
Investing Cash Flow	$-5.8M	↑ 8.91%
Financing Cash Flow	$194.8K	↓ 98.4%

	FY20	Y/Y Change
Operating Cash Flow	$22.7M	↑ 742.33%
Investing Cash Flow	$-119.8M	↑ 1972.35%
Financing Cash Flow	$683.7M	↑ 350804.4%

	FY21	Y/Y Change
Operating Cash Flow	$244.6M	↑ 977.94%
Investing Cash Flow	$-332.2M	↑ 177.38%
Financing Cash Flow	$-3.9M	↓ 100.57%

	FY22	Y/Y Change
Operating Cash Flow	$277.4M	↑ 13.4%
Investing Cash Flow	$-352.6M	↑ 6.13%
Financing Cash Flow	$-1.6M	↓ 58.11%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$19.9M	↓ 145.17%
Investing Cash Flow	$-34.4M	↓ 77.01%
Financing Cash Flow	$419.0K	↓ 191.48%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-106.0K	↓ 100.53%
Investing Cash Flow	$-12.8M	↓ 62.82%
Financing Cash Flow	$6.6M	↑ 1482.34%

Abcellera Biologics Technicals Summary

Sell

Neutral

Buy

Abcellera Biologics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Abcellera Biologics (ABCL) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Abcellera Biologics Inc	-27.1%	-3.7%	-51.95%	-71.74%	-96.03%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Abcellera Biologics Inc	12.33	NA	NA	-0.66	-0.15	-0.14	NA	3.57
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Abcellera Biologics Inc	Buy	$703.3M	-96.03%	12.33	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Abcellera Biologics

AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company's preclinical products are ABCL635 for metabolic and endocrine conditions; and ABCL575 for atopic dermatitis. It has a research collaboration and license agreement with Eli Lilly and Company; a research collaboration with Confo Therapeutics for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets; and strategic collaboration with Biogen Inc. to discover therapeutic antibodies for neurological conditions, as well as collaboration with Viking Global Investors and ArrowMark Partners. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

Organization	Abcellera Biologics
Employees	0
CEO	Dr. Carl L.G. Hansen Ph.D.
Industry	Healthcare

Management People of Abcellera Biologics

Name	Title
Dr. Carl L.G. Hansen Ph.D.	CEO, President & Chairperson
Mr. Andrew Booth M.B.A.	Chief Financial Officer
Dr. Veronique Lecault Ph.D.	CTO & Director
Mr. Tryn T. Stimart Esq., J.D., M.Sc.	Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer
Marcie Thiessen CPA, CGA	Senior Director of Finance & Accounting
Ms. Tiffany Chiu B.Sc., Ph.D.	Vice President of Communications
Graham Craig M.Sc.	Director of Corporate Development
Mr. Murray McCutcheon Ph.D.	Senior Vice President of Partnering
Mr. Neil Aubuchon B.A., M.B.A.	Chief Commercial Officer
Mr. Adam Clarke M.A.I.C.D., Ph.D.	Senior Vice President of Discovery

Important FAQs about investing in ABCL Stock from India :

What is Abcellera Biologics share price today?

Abcellera Biologics share price today stands at $2.39, Open: $2.37 ; Previous Close: $2.34 ; High: $2.41 ; Low: $2.27 ; 52 Week High: $5.13 ; 52 Week Low: $2.31.

The stock opens at $2.37, after a previous close of $2.34. The stock reached a daily high of $2.41 and a low of $2.27, with a 52-week high of $5.13 and a 52-week low of $2.31.

Can Indians buy Abcellera Biologics shares?

Yes, Indians can invest in the Abcellera Biologics (ABCL) from India.

With INDmoney, you can buy Abcellera Biologics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Abcellera Biologics at zero transaction cost.

How can I buy Abcellera Biologics shares from India?

It is very easy to buy Abcellera Biologics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Abcellera Biologics (ABCL) be purchased?

Yes, you can buy fractional shares of Abcellera Biologics with INDmoney app.

What are the documents required to start investing in Abcellera Biologics stocks?

To start investing in Abcellera Biologics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.